|
|
||||||||
Department of Physiology, University of Zurich, CH-8057 Zurich, Switzerland
| |
ABSTRACT |
|---|
|
|
|---|
The renal type II Na-Pi cotransport is the rate-limiting step in proximal tubular phosphate (Pi) reabsorption. Among the different "proximal tubular" cell lines, this transporter seem only to be expressed in opossum kidney cells (OK cells). We have isolated the 5'-flanking region of the ok-Npt2 gene (OK cell type II Na-Pi cotransporter) including exons 1-3 and containing a TFIID site (TATA box), a GCCAAT site, an AP1 site, and two microsatellite GGAA repeats. Major transcription initiation sites were determined by primer extension and rapid amplification of 5' cDNA ends (5'-RACE). A 327-bp fragment containing the TFIID and GCAAT element was driving the downstream luciferase reporter gene in homologous transfection assays. Slightly reduced promoter activity was observed with a 198-bp fragment containing the GCAAT element; shorter fragments were without activity. Promoter activity (327-bp fragment) could also be observed in transfections into HeLa cells but not in U937 human macrophage cells, MCT mouse kidney cortex cells, and MDCK cells. Different "physiological" stimuli known to be associated with altered proximal tubular Na-Pi cotransport activity are without effect on transcriptional activity in above homologous transfection experiments.
renal phosphate transporter; promoter; brush-border membrane; parathyroid hormone
| |
INTRODUCTION |
|---|
|
|
|---|
PHOSPHATE (Pi) reabsorption in the mammalian proximal tubule is altered under a variety of physiological and pathophysiological conditions (for review, see Refs. 3, 6, 22). Brush-border membrane Na-Pi cotransport was found to be the rate-limiting and pathophysiologically altered transport step. Two different brush-border membrane Na-Pi cotransporters have been identified by expression cloning techniques. Both, the type I and type II transporters were found to be exclusively located in the proximal tubule (for review, see Refs. 13, 19-21).
The type II Na-Pi cotransporter was identified from different animal species (9, 11, 16, 27, 29, 30, 32), including the opossum kidney-derived OK cell line (NaPi-4, Ref. 27), the only renal cell model expressing this transporter in significant amounts and frequently used to dissect the cellular and regulatory mechanisms involved in regulation of proximal tubular brush-border membrane Na-Pi cotransport (for review, see Ref. 22). The type II Na-Pi cotransporter is altered under a variety of physiological and pathophysiological conditions (for reviews, see Refs. 13, 19-21). Such regulatory phenomena were also seen in OK cells, for example, for parathyroid hormone (PTH; 5, 17, 23a), for alterations in the medium phosphate content (4, 18, 25, 26), for glucocorticoids (31), for thyroid hormone [triiodothyronine (T3); see Ref. 28], and for epidermal growth hormone (1).
The gene structure for the human and murine type II Na-Pi cotransporter gene (NPT2 and m-Npt2) has recently been determined (8). In the present study, we report the isolation and characterization of the 5'-flanking region of the OK cell type II Na-Pi cotransporter (ok-Npt2). We demonstrate that the ok-Npt2 promoter is active in the homologous OK cell system and hardly regulated by PTH or changes in the phosphate concentration in the medium.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Restriction enzymes were
obtained from Biofinex (Switzerland); DNA modifying enzymes, pGL3
luciferase reporter gene plasmids, and luciferase reporter gene assay
were from Promega (Madison, WI); pBluescript
SK+ plasmid was acquired from
Stratagene (La Jolla, CA); pCMV-LacZ was kindly provided by Dr. S. Rusconi, University of Zurich, Switzerland; pUC19
Nco I was obtained from Dr. H. Rhyner,
Children's Hospital of Zurich, Switzerland;
[
-32P]dCTP,
[
-35S]dATP, and
[
-32P]ATP were
purchased from NEN Research Products (Du Pont Canada) and
oligonucleotides were synthesized by Microsynth.
Gene isolation and mapping. Genomic
DNA from cultured OK cells (3B/2 clone) was extracted and dialyzed
according to current protocols (2). A genomic Southern blot
was hybridized with a
32P-labeled 5' end probe
(oligolabeling kit, Pharmacia) isolated from OK cell NaPi-4 cDNA (27)
in pSPORT1 (560-bp Mlu
I-Sac I, see Fig.
1) overnight at 42°C in 50% formamide
solution supplemented with 5% dextran sulfate (2). The filter was
washed twice with 2× SSC (1× SSC is 0.15 M NaCl and 0.015 M
sodium citrate, pH 7.0)-0.1% sodium dodecyl sulfate (SDS) at room
temperature and twice with 0.5× SSC-0.1% SDS at 55°C and
exposed on Kodak films with intensifying screen. A 12- to 15-kb
BamH I genomic fragment
could be detected on the genomic Southern blot. For construction of a
library, OK cell genomic DNA was digested with
BamH I and size fractionated on a
10-40% sucrose gradient. A fraction of 12-20 kb was ligated into
DASH II-BamH I (Stratagene),
and 106 plaque-forming units
were screened with the probe mentioned above. A genomic
clone of ~14 kb (
OKGL41.1, see Fig. 1) was isolated. A 6,000-bp
EcoR
I-BamH I fragment was subcloned into
pBluescript SK+ (Stratagene). The
DNA was purified in small quantities by spin columns (Qiagen).
|
The DNA was sequenced on both strands by the dideoxynucleotide chain termination method (Pharmacia Kit) and analyzed using the University of Wisconsin Genetics Computer Group Software, version 8.1.
Cell culture. The opossum kidney proximal tubule cell line (3B/2) and the human HeLa-S3 cell line were grown in Dulbecco's modified Eagle's medium-Ham's F12 (DMEM-F12) supplemented with 10% fetal calf serum (FCS) and 2 mM L-glutamine. The human macrophage cell line U937, the Madin-Darby canine kidney (MDCK) cell line, and the mouse kidney cortex cell line MCT (10) were cultivated in DMEM supplemented with 10% FCS. All cell cultures were kept at 37°C in a humidified environment (5% CO2, 95% air).
ok-Npt2 promoter-luciferase constructs:
electroporation and enzyme assays. A 327-bp genomic
fragment was generated by polymerase chain reaction (PCR) on the
6,000-bp EcoR
I-BamH I subfragment of
clone
OKGL41.1 with an antisense primer localized within exon 1 (NaPi4-31/50R, see Fig. 2) and a sense
primer starting at position
327 on the ok-Npt2 gene. The
fragment was digested with Apa I (located in the 5'-flanking region of ok-Npt2), subcloned into pBluescript SK+ cut with
Apa I and
Sma I (pB327), and sequenced. To
generate the luciferase reporter gene construct pGL327, the insert was excised from pB327 by BamH I and
Kpn I (both located within the polylinker of pBluescript SK+)
and subcloned into pGL3 basic vector digested by
Kpn I and
Bgl II. Genomic DNA fragments of 140 to 208 bp were generated by PCR on pB327 (mentioned above) with a
pBluescript SK+ primer (5'
CCATGATTACGCCAAGCTC 3') and different ok-Npt2-specific sense
primers. The construct pGL208 extends from position
154, pGL206
from
152, pGL198 from
144, pGL194 from
140, pGL173
from
119, pGL168 from
114, pGL140 from
86 and
pGL121 from
67, and the whole set of PCR generated fragments end
within exon 1 at position +54. The amplified DNA was digested with
BamH I (located in the polylinker of
pBluescript SK+), subcloned into
the pGL3 basic vector digested with
Bgl II and Sma I, and sequenced on both strands.
|
The luciferase reporter gene constructs pGL1700 and pGL4700 were
generated by linking a 1,400-bp Sac
I-Apa I or a 4,400-bp EcoR
I-Apa I subfragment of clone
OKGL
41.1 to the 327-bp Apa I-BamH I fragment mentioned above.
For standardization of the promoter activity in different cell lines,
the pGL3 promoter (pGL3-SV40, enhancerless simian virus promoter) and
the pGL3 basic vector (Promega) were used. As internal standard, a
-galactosidase-expressing vector pCMV-LacZ was cotransfected. Transient cell transfections were performed by electroporation. Approximately 107 cells in DMEM
without FCS were electroporated at 960 µF and 250 V with 5 µg (OK
cells), 10 µg (MCT, MDCK and U937), or 20 µg (HeLa-S3) of pGL3
constructs and equal amounts of pCMV-LacZ and plated on 3.5-cm diameter
dishes. The cells were harvested 48 h after transfection in 100 µl of
1× lysis buffer (Promega). The
-galactosidase reaction was
performed in 0.1 M NaPO4, pH 7.5, 4 mg/ml
o-nitrophenyl-
-galactopyranoside, and 1 mM MgCl2 for 30 min to 4 h
at 37°C, and the optical density was measured at 420 nm. Luciferase
was assayed with a luciferase kit (Promega) and measured in a
luminometer (Lumac Biocounter M1500).
For studies related to the effect of PTH and phosphate concentration,
the electroporated cells were plated into 24-well plates in triplicate
and kept for 4 h in DMEM-F12 supplemented with 10% FCS to improve
vitality. Subsequently cultured cells were switched for 24 h to the
corresponding medium (22 mM
, 5%
CO2, and pH 7.4) without FCS. For
studies with altering phosphate concentration, cells were kept in
phosphate-free DMEM (Sigma) supplemented with 0.1, 0.9, and 1.5 mM
phosphate. To determine the hormonal effect, the cells were either
incubated in 10
8 M PTH or
in its vehicle. The cells were used for uptake studies and then
harvested in the reporter gene lysis buffer for determination of
luciferase and
-galactosidase activity. Protein concentration and
Pi uptake was performed as
described (23a).
Rapid amplification of 5' cDNA ends (5'-RACE). For 5'-RACE OK cell total RNA (10 µg) isolated with Trizol (GIBCO-BRL) was retrotranscribed with 20 U Moloney murine leukemia virus reverse transcriptase (MLV-RT, Promega) using a NaPi-4 cDNA-specific (OK cell; Ref. 27) primer (nt 386-405; antisense). The product was cleaned by the GeneClean II kit (BIO 101). The 5' end of the cDNA was extended by a polynucleotide transferase (30 U, GIBCO-BRL) in presence of 0.4 mM dATP. PCR was performed with a second NaPi-4 cDNA-specific primer (nt 276-291; antisense), a T17 adapter primer, and an adapter primer (7). The PCR product was digested with Sal I (located in the adapter primer) and Nco I (NaPi-4 cDNA) and subcloned into pUC19 Nco and sequenced. By this method we obtained four different extension products (see RESULTS).
Primer extension. A quantity of 10 µg of OK cell total RNA (see above) was retrotranscribed with 20 U
MLV-RT (Promega) in presence of 80,000 cpm of a
32P-labeled 5' NaPi-4
cDNA-specific (OK cell; Ref. 27) primer (nt 45-65 or nt
50-70, both antisense). Labeling of the oligonucleotide was
performed with 8 U polynucleotide kinase (Promega) in presence of 50 µCi [
-32P]ATP.
The extension product was ethanol precipitated and loaded on a 6%
sequencing gel in presence of a sequencing ladder performed with the
primers mentioned above on genomic DNA (pGL327).
| |
RESULTS |
|---|
|
|
|---|
Structure of the OK cell type II
Na/Pi-cotransporter (Npt2)
5'-flanking region.
The organization of the ok-Npt2 promoter region was determined by
screening a genomic OK cell
DASH
BamH I library with a 560-bp
Mlu
I-Sac I fragment representing the very
5' end of the OK cell type II
Na-Pi cotransporter cDNA (see Fig.
1). A single clone
OKGL41.1 of ~14 kb was obtained, and a 6,000-bp
EcoR
I-BamH I subfragment was subcloned
into plasmid pBluescript SK and fully sequenced (see Figs. 1 and 2). It
contained in its 3' region exon 1 corresponding to nt 12-64,
exon 2 corresponding to nt 65-177, and exon 3 corresponding to nt
178-333 of the OK cell NaPi-4 cDNA (27). A comparison of the
intron/exon boundaries is presented in Table
1. In ok-Npt2, exon 2 contains only 1 base
of 5'-untranslated region, in contrast to the m-Npt2
and h-NPT2 where the translation initiation site is also on exon 2 but
further downstream (8). A high homology in the organization between
mouse, human, and opossum NPT/Npt2 genes is suggested by the identity
of encoded amino acids and coding phase usage at the intron/exon
boundaries (Table 1; introns 2 and 3).
|
304, underlined) but no classic Sp1 binding site,
glucocorticoid (GRE), T3 (TRE), or
vitamin D3 (VDRE) responsive
elements could be detected. (A quantity of 6 kb of 5'-flanking
sequence have been analyzed for ok-Npt2; GenBank/EMBL Data Bank;
accession no. AJ003021).
|
|
|
|
8 M) for 24 h.
PTH had no downregulatory effect on the activity of the ok-Npt2
promoter in the OK cell line (Fig.
7A).
|
| |
DISCUSSION |
|---|
|
|
|---|
Opossum kidney cells (OK cells) are the only renal cell line expressing the type II Na-Pi cotransporter (NaPi-4) in significant amounts. Furthermore, in this cell line the transporter is regulated like in the proximal tubule (for review see Refs. 13, 19-22). Therefore, OK cells are ideally suited in homologous transfection studies to characterize structure and function relationships of the type II Na-Pi cotransport promoter.
We report the characterization of the 5'-flanking region of the
ok-Npt2 gene including the promoter region and exons 1 to 3. The first
two exons are separated by a relatively small intron of 443 bp. Within
the 5'-flanking region and adjacent to exon 3, two extended GGAA
repeats (microsatellites) of unknown function are
present. The promoter/enhancer region of the ok-Npt2 gene contains a
typical TATA box and a conserved GCAAT element, which seem to enhance
promoter activity. These motifs are also found at corresponding sites
within the published human and murine type II
Na-Pi cotransporter genes (Fig.
3). In all three species the translation start site is within the
second exon. For both the murine and the OK cell Npt2 genes, the
conserved TATA box is 31 bp away from the major transcription
initiation site (see Fig. 3). In the ok-Npt2 gene an AP1 site is
present at position
304; two AP1 sites have also been identified
in the human NPT2 gene but are located further upstream (29).
In contrast to OK cells, no promoter activity could be observed in the human macrophage cell line U397, in the Madin Darby canine kidney MDCK cell line of distal tubular origin, and in the murine kidney cortex cell line MCT, and we could prove by RT-PCR and Northern blotting that in the human, murine, and dog cell lines an intrinsic type II Na-Pi cotransporter is absent (data not shown). These results indicate that an element might be present within the 327-bp fragment derived from the ok-Npt2 gene that promotes transcriptional activity in OK cells. The negative RT-PCR result with the murine cell line MCT, a SV40 transformed cell line derived from microdissected mice proximal tubules (10), indicates a lack of cell differentiation. In Northern hybridizations, we could also not observe an expression of the type II Na-Pi cotransporter in "proximal tubular" LLC-PK cells (17; data not shown). It remains unknown why only OK cells have retained the capacity to express the type II Na-Pi cotransporter in physiological relevant amounts and with the basic and regulatory characteristics of the type II Na-Pi cotransporter in its proximal tubular environment.
Dietary phosphorus and PTH are important regulators of renal phosphate reabsorption. Dietary phosphate restriction for several days leads in rats to an increased brush-border membrane type II Na-Pi cotransporter expression on protein and mRNA level that cannot be prevented by actinomycin D (14, 15). Interestingly, the early effects (2 h) are independent of changes in mRNA content. A similar phenomenon can also be observed in OK cells. In our studies Pi deprivation led to an increase in apical Na-Pi cotransport activity that could not be prevented by actinomycin D (4). Similar to the rat studies, Pi deprivation of OK cells (clone 3B/2) led at early time points to transport alterations not paralleled by alteration in mRNA content (18). Under chronic conditions (24 h), Pi deprivation of OK cells led to an increased apical expression of Na-Pi cotransport activity that was not always paralleled by an increase in mRNA content (Ref. 18; M. Custer and J. Biber, unpublished observations). These data suggest that Pi deprivation (in the diet or medium) leads to an altered Na-Pi cotransport activity that can occur independent of an increased transcription rate. The data obtained from the reporter gene studies with the ok-Npt2 promoter in the "responsive" OK cell environment are in direct support of the interpretations mentioned above.
For PTH we could recently show that inhibition of rat proximal tubular Na-Pi cotransport is related to a withdrawal of the protein from the apical surface; also, the mRNA level was found to be reduced after PTH administration (2 h) to parathyroidectomized rats (12). Similar results were obtained in the OK cell system, where PTH treatment leads in short-term experiments to a rapid internalization of the Na-Pi cotransporter protein from the apical membrane (23). The present reporter gene studies were not able to detect a change in type II Na-Pi cotransporter promoter activity after prolonged PTH treatment (24 h).
We have also performed reporter gene studies with additional hormones
known to regulate the type II
Na-Pi cotransporter in OK cells.
Experiments were performed for 24 h with dexamethasone (10
6 M, see Ref. 31),
T3
(10
7 M, see Ref. 28), with
insulin-like growth factor I
(10
7 M), and with epidermal
growth factor (10
8 M, see
Ref. 1). For all these conditions, we could not document reproducible and significant changes in transcriptional activity (data
not shown). In contrast to our previous studies (~50% increase, see
Ref. 28), we were unable to observe a
T3-induced increase in specific
mRNA content (data not shown). Although we have no satisfactory
explanation for this apparent discrepancy, we must conclude that
T3 effects on promoter activity
seem to be rather small and that present experimental conditions (e.g.,
cell passage number and source of FCS in culture medium) might have
prevented detection of small alterations in promoter
activity and specific mRNA-content.
The present results indicate that the ok-Npt2 promoter is "constitutively" active and contains elements required for cell-specific expression. We were unable to document large changes in promoter activity for different modulators of the type II Na-Pi cotransporter in renal cells (proximal tubule and OK cells), indicating that the protein abundance might be regulated predominantly at the posttranscriptional level.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. R. Wuethrich for supplying us with various kidney cell lines, Dr. R. Wenger, Dr. J. Biber, and Dr. F. Verrey for helpful discussions, and C. Gasser for preparing the figures.
| |
FOOTNOTES |
|---|
The nucleotide sequence reported in this study has been submitted to the GenBank/EMBL Data Bank with accession no. AJ003021.
This work was supported by a Swiss National Science Foundation Grants 32.30785 and 31.46523 (to H. Murer).
Address for reprint requests: H. Hilfiker, Institute of Physiology, Univ. of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Received 12 May 1997; accepted in final form 18 September 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arar, M.,
M. Baum,
J. Biber,
H. Murer,
and
M. Levi.
Epidermal growth factor inhibits Na-Pi cotransport and mRNA in OK cells.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F309-F314,
1995
2.
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith,
and
K. Struhl.
Current Protocols in Molecular Biology. New York: Wiley, 1995.
3.
Berndt, T. J.,
and
F. G. Knox.
Renal regulation of phosphate excretion.
In: The Kidney: Physiology and Pathophysiology, edited by D. W. Seldin,
and G. Giebisch. New York: Raven, 1992, p. 2511-2532.
4.
Biber, J.,
J. Forgo,
and
H. Murer.
Modulation of Na+-Pi cotransport in opossum kidney cells by extracellular phosphate.
Am. J. Physiol.
255 (Cell Physiol. 24):
C155-C161,
1988
5.
Caverzasio, J.,
R. Rizzoli,
and
J. P. Bonjour.
Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line.
J. Biol. Chem.
261:
3233-3237,
1986
6.
Dennis, V. W.
Phosphate homeostasis.
In: Handbook of Physiology. Renal Physiology. Bethesda, MD: Am. Physiol. Soc., 1992, sect. 8, vol. 2, chapt. 37, p. 1785-1815.
7.
Frohman, M. A.
PCR Protocols: A Guide to Methods and Applications, edited by M. A. Innes,
D. H. Gelfand,
J. J. Sninsky,
and T. J. White. New York: Academic, 1990, p. 28-38.
8.
Hartmann, C. M.,
A. S. Hewson,
C. H. Kos,
H. Hilfiker,
Y. Soumounou,
H. Murer,
and
H. S. Tenenhouse.
Structure of murine and human renal type II Na+-phosphate cotransporter genes (Npt2 and NPT2).
Proc. Natl. Acad. Sci. USA
93:
7409-7414,
1996
9.
Hartmann, C. M.,
C. A Wagner,
A. E. Busch,
D. Markovich,
J. Biber,
F. Lang,
and
H. Murer.
Transport characteristics of a murine renal Na/Pi cotransporter.
Pflügers Arch.
430:
830-836,
1995[Medline].
10.
Haverty, T. P.,
C. J. Kelly,
W. H. Hines,
P. S. Amenta,
M. Watanabe,
R. A. Harper,
N. A. Kefalides,
and
E. G. Neilson.
Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis.
J. Cell Biol.
107:
1359-1368,
1988
11.
Helps, C.,
H. Murer,
and
J. McGivan.
Cloning, sequence analysis and expression of the cDNA encoding a sodium-dependent phosphate transporter from the bovine renal epithelial cell line NBL.
Pflügers Arch.
228:
927-930,
1995.
12.
Kempson, S. A.,
M. Lotscher,
B. Kaissling,
J. Biber,
H. Murer,
and
M. Levi.
Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F784-F791,
1995
13.
Levi, M.,
S. A. Kempson,
M. Lotscher,
J. Biber,
and
H. Murer.
Molecular regulation of renal phosphate transport.
J. Membr. Biol.
154:
1-9,
1996[Medline].
14.
Levi, M.,
M. Lotscher,
V. Sorribas,
M. Custer,
M. Arar,
B. Kaissling,
H. Murer,
and
J. Biber.
Cellular mechanisms of acute and chronic adaptation of rat renal Pi transporter to alterations in dietary Pi.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F900-F908,
1994
15.
Lotscher, M.,
B. Kaissling,
J. Biber,
H. Murer,
and
M. Levi.
Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content.
J. Clin. Invest.
99:
1302-1312,
1997[Medline].
16.
Magagnin, S.,
A. Werner,
D. Markovich,
V. Sorribas,
G. Stange,
J. Biber,
and
H. Murer.
Expression cloning of human and rat renal cortex Na/Pi cotransport.
Proc. Natl. Acad. Sci. USA
90:
5979-5983,
1993
17.
Malmström, K.,
and
H. Murer.
Parathyroid hormone inhibits phosphate transport in OK cells but not in LLC-PK1 and JTC-12.P3 cells.
Am. J. Physiol.
251 (Cell Physiol. 20):
C23-C31,
1986
18.
Markovich, D.,
T. Verri,
V. Sorribas,
J. Forgo,
J. Biber,
and
H. Murer.
Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability.
Pflügers Arch.
430:
459-463,
1995[Medline].
19.
Murer, H.,
and
J. Biber.
A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation.
Pflügers Arch.
433:
379-389,
1997[Medline].
20.
Murer, H.,
and
J. Biber.
Molecular mechanisms of renal apical Na/phosphate cotransport.
Annu. Rev. Physiol.
58:
607-618,
1996[Medline].
21.
Murer, H.,
and
J. Biber.
Renal sodium-phosphate cotransport.
Curr. Opin. Nephrol. Hypertens.
3:
504-510,
1994[Medline].
22.
Murer, H.,
and
J. Biber.
Renal tubular phosphate transport: cellular mechanisms.
In: The Kidney: Physiology and Pathophysiology, edited by D. W. Seldin,
and G. Giebisch. New York: Raven, 1992, p. 481-509.
23.
Pfister, M. F.,
E. Lederer,
J. Forgo,
U. Ziegler,
M. Lotscher,
E. S. Quabius,
J. Biber,
and
H. Murer.
Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters.
J. Biol. Chem.
272:
20125-20130,
1997
23a.
Quamme, G.,
S. Pelech,
J. Biber,
and
H. Murer.
Abnormalities of parathyroid hormone-mediated signal transduction mechanisms in opossum kidney cells.
Biochim. Biophys. Acta
1223:
107-116,
1994[Medline].
24.
Reshkin, S. J.,
J. Forgo,
and
H. Murer.
Functional asymmetry of phosphate transport and its regulation in opossum kidney cells: phosphate transport.
Pflügers Arch.
416:
624-631,
1990[Medline].
25.
Saxena, S.,
and
M. Allon.
The role of cytosolic calcium in chronic adaptation to phosphate depletion in opossum kidney cells.
J. Biol. Chem.
271:
3902-3906,
1996
26.
Saxena, S.,
L. Dansby,
and
M. Allon.
Adaptation to phosphate depletion in opossum kidney cells.
Biochem. Biophys. Res. Commun.
216:
141-147,
1995[Medline].
27.
Sorribas, V.,
D. Markovich,
G. Hayes,
G. Stange,
J. Forgo,
J. Biber,
and
H. Murer.
Cloning of a Na/Pi cotransporter from opossum kidney cells.
J. Biol. Chem.
269:
6615-6621,
1994
28.
Sorribas, V.,
D. Markovich,
T. Verri,
J. Biber,
and
H. Murer.
Thyroid hormone stimulation of Na/Pi-cotransport in opossum kidney cells.
Pflügers Arch.
431:
266-271,
1995[Medline].
29.
Taketani, Y.,
K.-I. Miyamoto,
K. Katai,
M. Chikamori,
S. Tatsumi,
H. Segawa,
H. Yamamoto,
K. Morita,
and
E. Takeda.
Gene structure and functional analysis of the human Na+/phosphate co-transporter.
Biochem. J.
324:
927-934,
1997.
30.
Verri, T.,
D. Markovich,
C. Perego,
F. Norbis,
G. Stange,
V. Sorribas,
J. Biber,
and
H. Murer.
Cloning of a rabbit renal Na-Pi cotransporter, which is regulated by dietary phosphate.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F626-F633,
1995
31.
Vrtovsnik, F.,
M. Jourdain,
G. Cherqui,
J. Lefebvre,
and
G. Friedlander.
Glucocorticoid inhibition of Na-Pi cotransport in renal epithelial cells is mediated by protein kinase C.
J. Biol. Chem.
269:
8872-8877,
1994
32.
Werner, A.,
H. Murer,
and
R. K. H. Kinne.
Cloning and expression of a renal Na-Pi cotransport system from flounder.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F311-F317,
1994
This article has been cited by other articles:
![]() |
S. J. Khundmiri, A. Ahmad, R. E. Bennett, E. J. Weinman, D. Steplock, J. Cole, P. D. Baumann, J. Lewis, S. Singh, B. J. Clark, et al. Novel regulatory function for NHERF-1 in Npt2a transcription Am J Physiol Renal Physiol, April 1, 2008; 294(4): F840 - F849. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Werner and R. K. H. Kinne Evolution of the Na-Pi cotransport systems Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R301 - R312. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Murer, N. Hernando, I. Forster, and J. Biber Proximal Tubular Phosphate Reabsorption: Molecular Mechanisms Physiol Rev, October 1, 2000; 80(4): 1373 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shachaf, K. L. Skorecki, and M. Tzukerman Role of AP2 consensus sites in regulation of rat Npt2 (sodium-phosphate cotransporter) promoter Am J Physiol Renal Physiol, March 1, 2000; 278(3): F406 - F416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kido, K.-i. Miyamoto, H. Mizobuchi, Y. Taketani, I. Ohkido, N. Ogawa, Y. Kaneko, S. Harashima, and E. Takeda Identification of Regulatory Sequences and Binding Proteins in the Type II Sodium/Phosphate Cotransporter NPT2 Gene Responsive to Dietary Phosphate J. Biol. Chem., October 1, 1999; 274(40): 28256 - 28263. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Whyte, C. Li, R. B. Thomson, S. L. Nix, R. Zanjani, S. L. Karp, P. S. Aronson, and P. Igarashi Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity Am J Physiol Renal Physiol, October 1, 1999; 277(4): F587 - F598. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Jehle, H. Hilfiker, M. F. Pfister, J. Biber, E. Lederer, R. Krapf, and H. Murer Type II Na-Pi cotransport is regulated transcriptionally by ambient bicarbonate/carbon dioxide tension in OK cells Am J Physiol Renal Physiol, January 1, 1999; 276(1): F46 - F53. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Tenenhouse, S. Roy, J. Martel, and C. Gauthier Differential expression, abundance, and regulation of Na+-phosphate cotransporter genes in murine kidney Am J Physiol Renal Physiol, October 1, 1998; 275(4): F527 - F534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Taniyama, K. Sato, A. Sugawara, A. Uruno, Y. Ikeda, M. Kudo, S. Ito, and K. Takeuchi Renal Tubule-specific Transcription and Chromosomal Localization of Rat Thiazide-sensitive Na-Cl Cotransporter Gene J. Biol. Chem., July 6, 2001; 276(28): 26260 - 26268. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Soumounou, C. Gauthier, and H. S. Tenenhouse Murine and human type I Na-phosphate cotransporter genes: structure and promoter activity Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1082 - F1091. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |